AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vidplack M 500mg/50mg Tablet

Prescription Icon
Prescription Required

Marketer

Placker Life Sciences

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Vidplack M 500mg/50mg Tablet

Diabex Duo 500mg/50mg tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps prevent severe diabetic complications like renal impairment and vision loss, potentially lowering the risk of cardiovascular events. Diabex Duo may be prescribed as monotherapy or in conjunction with other antidiabetic agents. Optimal results require adherence to a balanced diet and regular physical activity. Dosage is tailored to individual needs, considering current health status, blood glucose levels, and concurrent medications. Consuming the tablets with food minimizes gastrointestinal discomfort. Consistent daily administration at the same time maximizes therapeutic benefits; discontinuation should only occur under medical supervision. Effective blood sugar control reduces the risk of long-term complications. Continued adherence to the prescribed diet and exercise regimen is crucial. Lifestyle modifications are integral to diabetes management. Common side effects include diarrhea, nausea, vomiting, dyspepsia, headache, pharyngitis, asthenia, GERD, diaphoresis, and anorexia. Hypoglycemia, a potential side effect when used with insulin or sulfonylureas, necessitates patient awareness of its symptoms and management. This medication isn't suitable for all patients. Prior to commencing treatment, inform your physician of any history of kidney, liver, or heart disease, pancreatic disorders, or significant alcohol consumption. Pregnant or lactating women should seek medical counsel before use. Drug interactions are possible; disclose all medications to your doctor to ensure safety. Alcohol should be limited due to its hypoglycemic effects. Your doctor will monitor kidney function and blood glucose levels throughout treatment.

Primary Ingredients of Vidplack M 500mg/50mg Tablet

No text provided. Please provide the text you would like me to rephrase.

Uses of Vidplack M 500mg/50mg Tablet

Managing type 2 diabetes

Major Benefits of Vidplack M 500mg/50mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vidplack M 500mg/50mg Tablets should be administered with a meal.

Common Side effects of Vidplack M 500mg/50mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vidplack M 500mg/50mg Tablet:

Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Vidplack M 500mg/50mg tablets with a meal.

How Vidplack M 500mg/50mg Tablet works:

Diabetic dual-action tablet, Vidplack M, contains 500mg of one antidiabetic agent and 50mg of another.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Vidplack M 500mg/50mg Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Vidplack M 500mg/50mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Vidplack M 500mg/50mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Vidplack M 500mg/50mg tablets cautiously. Dosage modification may be necessary; physician consultation is advised.

LiverLiverUNSAFE

The use of Vidplack M 500mg/50mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Vidplack M 500mg/50mg Tablet :

Should you forget a Vidplack M 500mg/50mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vidplack M 500mg/50mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Vidplack M 500mg/50mg Tablet

Vidplack M 500mg/50mg Tablets rarely cause hypoglycemia (low blood sugar) by themselves. However, low blood sugar can result from inadequate calorie intake while using this medication. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. These symptoms are more pronounced if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Regular blood sugar monitoring is crucial. Always keep glucose tablets, honey, or fruit juice readily available.
Nausea and vomiting are possible side effects of Vidplack M 500mg/50mg Tablet. If vomiting occurs, sip small amounts of water or other fluids frequently. Persistent vomiting or signs of dehydration (dark, strong-smelling urine, infrequent urination) warrant immediate medical attention. Do not self-medicate; consult your doctor before taking any other medication.
Vidplack M 500mg/50mg Tablets are contraindicated in patients with allergies to its components or excipients, and should not be used by those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Vidplack M 500mg/50mg tablets combine metformin (a biguanide) and vildagliptin, both anti-diabetic medications. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Vidplack M 500mg/50mg Tablets can cause lactic acidosis, a serious medical emergency involving excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Seek immediate medical attention and discontinue Vidplack M 500mg/50mg Tablets if these symptoms occur.
Prolonged use of Vidplack M 500mg/50mg Tablet can lead to vitamin B12 deficiency by hindering its absorption in the stomach, potentially resulting in anemia and neurological complications if left unaddressed.
Vidplack M 500mg/50mg Tablet is safe when used as directed by your doctor. However, even with correct dosage, you may experience side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, or low blood sugar (hypoglycemia, especially if also taking insulin or sulphonylurea). Report any persistent issues to your physician.
Vidplack M 500mg/50mg Tab...
214
MRP 248
13% off